Human papillomavirus disease in


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 07 06 2024
accepted: 08 08 2024
medline: 13 9 2024
pubmed: 13 9 2024
entrez: 13 9 2024
Statut: epublish

Résumé

Patients with pathogenic variants in the GATA Binding Protein 2 ( A 17-year retrospective review of medical records, including laboratory, histopathology and cytopathology records was performed for patients diagnosed with Of 68 patients with Females with

Identifiants

pubmed: 39267745
doi: 10.3389/fimmu.2024.1445711
pmc: PMC11390362
doi:

Substances chimiques

GATA2 Transcription Factor 0
GATA2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1445711

Informations de copyright

Copyright © 2024 Dancy, Stratton, Pichard, Marciano, Cowen, McBride, Van Doorslaer, Merideth, Salmeri, Hughes, Heller, Parta, Hickstein, Kong, Holland and Zerbe.

Déclaration de conflit d'intérêts

PS, also add participated in an Endometriosis Research Day at the Open Endoscopy Forum Cambridge, Massachusetts, and reviewed a book proposal on endometriosis for Elsevier. Outside of this work, PS has received royalties from UpToDate for a section about acute pelvic pain, from Frontiers in Reproductive Health as Specialty Chief Editor, Gynecology, and participated in an AbbVie advisory board. PS also participated in an Endometriosis Research Day at the Open Endoscopy Forum Cambridge, Massachusetts, and reviewed a book proposal on endometriosis for Elsevier. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Références

J Allergy Clin Immunol. 2012 Nov;130(5):1030-48
pubmed: 23036745
Blood. 2014 Feb 6;123(6):809-21
pubmed: 24227816
J Am Acad Dermatol. 2013 Oct;69(4):e189-90
pubmed: 24034395
J Low Genit Tract Dis. 2019 Apr;23(2):87-101
pubmed: 30907775
Clin Infect Dis. 2016 Jul 1;63(1):41-7
pubmed: 27169477
Transplant Cell Ther. 2021 May;27(5):435.e1-435.e11
pubmed: 33965189
Biol Blood Marrow Transplant. 2014 Dec;20(12):1940-8
pubmed: 25111582
J Clin Med. 2015 Jan 29;4(2):260-81
pubmed: 26239127
Arch Dermatol. 2010 Aug;146(8):931-2
pubmed: 20713842
Blood. 2006 Mar 1;107(5):1857-63
pubmed: 16254139
Infect Agent Cancer. 2009 Jun 01;4:8
pubmed: 19486508
N Engl J Med. 2021 Sep 2;385(10):921-929
pubmed: 34469647
Vaccine. 2012 Nov 20;30 Suppl 5:F12-23
pubmed: 23199955
Blood. 2011 Sep 8;118(10):2653-5
pubmed: 21670465
JAMA Oncol. 2020 May 1;6(5):696-705
pubmed: 32105293
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Blood. 2011 Sep 8;118(10):2656-8
pubmed: 21765025
Int J Cancer. 2019 Apr 15;144(8):1975-1982
pubmed: 30246864
Obstet Gynecol. 2017 Jun;129(6):1
pubmed: 28346275
J Am Acad Dermatol. 2015 Jun;72(6):1082-4
pubmed: 25981006
J Infect Dis. 2013 Jul 15;208(2):330-9
pubmed: 23596319
J Infect Dis. 2004 Jul 1;190(1):37-45
pubmed: 15195241
Biol Blood Marrow Transplant. 2018 Jun;24(6):1250-1259
pubmed: 29412158
Sex Transm Dis. 2021 Apr 1;48(4):273-277
pubmed: 33492097
Cells. 2021 Nov 10;10(11):
pubmed: 34831327
Blood. 2014 Feb 6;123(6):863-74
pubmed: 24345756
Blood. 2005 Jul 15;106(2):477-84
pubmed: 15811962
Blood. 2010 Feb 25;115(8):1519-29
pubmed: 20040766
Tumour Biol. 2015 Sep;36(9):6633-44
pubmed: 26242271
Br J Dermatol. 2003 Sep;149(3):627-33
pubmed: 14511000
J Pathol. 2001 May;194(1):51-8
pubmed: 11329141
Blood. 2013 Apr 4;121(14):2669-77
pubmed: 23365458
Psychooncology. 2016 Jun;25(6):656-62
pubmed: 26403828
Orphanet J Rare Dis. 2012 Sep 25;7:71
pubmed: 23009155
Curr Protoc Microbiol. 2016 Nov 18;43:14B.9.1-14B.9.20
pubmed: 27858973
Nat Rev Dis Primers. 2016 Dec 01;2:16086
pubmed: 27905473

Auteurs

Ehren Dancy (E)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.

Pamela Stratton (P)

Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.

Dominique C Pichard (DC)

National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, United States.

Beatriz E Marciano (BE)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Edward W Cowen (EW)

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.

Alison A McBride (AA)

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Koenraad Van Doorslaer (K)

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Department of Immunobiology, College of Medicine, BIO5 Institute, Cancer Biology Graduate Interdisciplinary Program, Genetics Graduate Interdisciplinary Program, University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States.

Melissa A Merideth (MA)

Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.

Noemi Salmeri (N)

Gynecology/Obstetrics Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, United States.

Marybeth S Hughes (MS)

Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, United States.

Theo Heller (T)

Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.

Mark Parta (M)

Retired, Bethesda, MD, United States.

Dennis D Hickstein (DD)

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Heidi H Kong (HH)

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, United States.

Steven M Holland (SM)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Christa S Zerbe (CS)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH